Ready for Good News, page-4

First 4 Last

Share
Profile

Follow
Northen_munky

9,838 Posts.

1451

18/03/16

12:08

Post #: 17309710
Share

Originally posted by Parsifal ↑

Did I say we wanted some publicity that was more useful than textile product suppliers admitting that they have been using toxic chemicals.

Well I think we've just got it.

This release from AJX is a big deal. It's the first real wedge against the suppliers of halogenated fire retardants. Up until now it's been threats of bans but now it's real.

And we are not talking about the "left wing pinko state of California" having taken action. We are talking serious, intellectual Washington DC. That's a huge deal. I'd say watch this page as state by state they fall and pressure at federal level follows.

But more to the point it creates an interesting dilemma for producers. You can't use a fire retardant in one state but it's not logical to set up a supply chain for a single state either. So your choice is to use Alexium or to use nothing (high risk in a litigious society like America - so you knew a non toxic solution was available but you did nothing?)

I wonder how many chemical manufacturers have been blindsided by this announcement. I wonder what the next moves will be? Mmmm I'm watching very carefully but if this doesn't increase the future potential of AJX the world is more crazy than it appears already

Thank goodness Nick, Dirk and the team
Have worked so hard to have the right processes in place to capitalise on this.

The timing isn't really too bad I'd have thought. In retrospect I'd suspect that Alexium would have struggle to manage big orders last year. I'm much more comfortable now if this turns into an avalanche of orders

Expand

Good post Parsifal..i'm always happy when the sensible one posts..lol

Regards

AJX Price at posting: 72.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

AUG

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

RNU

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

TX3

Canadian fieldwork yields multiple pegmatites for Trinex

TLX

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

There are more pages in this discussion • 3 more messages in this thread...

First 4 Last

Add AJX (ASX) to my watchlist

(20min delay)
Last 1.1¢		Change 0.000(0.00%)		Mkt cap ! $17.18M

Open	High	Low	Value	Volume
1.1¢	1.1¢	1.1¢	$358	32.5K

Buyers (Bids)

No.	Vol.	Price($)
2	97500	1.1¢

Sellers (Offers)

Price($)	Vol.	No.
1.2¢	2591500	2

View Market Depth

No.	Vol.	Price($)
2	97500	0.011
6	4732035	0.010
3	511210	0.009
2	182600	0.008
1	200000	0.007

Price($)	Vol.	No.
0.012	2591500	2
0.013	1758914	3
0.014	363311	2
0.015	36316	2
0.017	15000	1

Last trade - 11.27am 11/07/2024 (20 minute delay)

AJX (ASX) Chart

Ready for Good News, page-4

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Canadian fieldwork yields multiple pegmatites for Trinex

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ready for Good News, page-4

Top Stories

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Canadian fieldwork yields multiple pegmatites for Trinex

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News